IR
IRIDEX Corporation
IRIX · NASDAQ
$0.63 -0.79% (-$0.01)
1M -11.54%
Market Cap $10.9M
P/E Ratio -
Div. Yield -
ROE 78.94%
Bulios Fair Price
$0.88
40.8% upside
Current Price
$0.63
Undervalued Fair Value Overvalued
According to Bulios Fair Price, IRIX is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
83 /100
Cheap P/S 0.21x
P/B 3.00x
P/E N/A
Growth
5 /100
Declining Rev. growth 2.58%
Book val. growth 34.14%
EPS growth N/A
Profitability
14 /100
Weak Gross margin 36.23%
FCF margin 3.43%
Net margin 6.88%
Quality
15 /100
Poor ROIC 20.41%
Asset turnover 1.89x
ROE 78.94%
Debt
97 /100
Low Debt/Equity 0.06x
Current ratio 1.82x
Int. coverage N/A
Stability
70 /100
Stable Beta 0.63x
Profitable years 0
Rev. volatility 9.22%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about IRIX
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Patrick Mercer
Employees
93
Headquarters
Mountain View
Upcoming events
17 NOV
Earnings
Upcoming earnings report